Balaji Amines Ltd

Balaji Amines Expands with New Projects & Solar Push 🌱 | Q2FY26 Insights 📊

- Q2FY26 revenue: ₹341 crore (vs ₹358Cr in Q1FY26).

- Volumes: 26,165 MT (slightly lower than 26,348 MT in Q2FY25).

- EBITDA: ₹67 crore (19% margin), PAT: ₹37.10 crore (EPS: ₹10.67/share).

- Zero-debt standalone status maintained.

- New projects: DME plant, N-Methyl Morpholine (NMM), upgraded Acetonitrile (ACN) – commissioning FY2025-26 to FY2026-27.

- Subsidiary Balaji Speciality Chemicals investing ₹750Cr (Mega Project status) for HCN & NaCN production.

- 8 MW solar plant operational to cut costs & emissions.

- Balaji Sarovar Hotel (Solapur) at 75% occupancy in Q2FY26.

- Export revenue contribution: 12.8% in FY25.

- Awards: ‘Rasayan Udyog Shri’ & CSR recognitions.

- Diversified portfolio: 40+ amines, derivatives & specialty chemicals.